{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:43:20Z","timestamp":1794491000074,"version":"4.9.1"},"reference-count":20,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>The adverse effects of the COVID-19 vaccine have been discovered as the rapid application of the vaccines continues. Neurological complications such as transverse myelitis raise concerns as cases were observed in clinical trials. Transverse myelitis is a rare immune-mediated disease with spinal cord neural injury, resulting in neurological deficits in the motor, sensory, and autonomic system. Vaccine-related transverse myelitis is even rarer. We present a case of acute transverse myelitis after vaccination against COVID-19 with the ChAdOx1 nCOV-19 vaccine (AZD1222), which was the first case reported in Taiwan. Although it rarely occurs, post-vaccination neurological complications should not be ignored. As the pandemic of SARS-CoV-2 continues to spread and concern about vaccination efficacy and safety rises, heterologous vaccination were implemented in health public policy in several countries. A literature review of several clinical trials shows promising effects of mix-and-match vaccination. Further study on different combinations of vaccines can be expected.<\/jats:p>","DOI":"10.3390\/medicina57101010","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T10:39:20Z","timestamp":1632739160000},"page":"1010","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Acute Transverse Myelitis after COVID-19 Vaccination"],"prefix":"10.3390","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5633-4478","authenticated-orcid":false,"given":"Yu-Ting","family":"Hsiao","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi City 600, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2662-1206","authenticated-orcid":false,"given":"Ming-Jen","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi City 600, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi City 600, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0120-0181","authenticated-orcid":false,"given":"Chi-Feng","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi City 600, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"653786","DOI":"10.3389\/fimmu.2021.653786","article-title":"Acute Transverse Myelitis (ATM): Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events with the ChAdOx1 nCoV-19 Vaccine (AZD1222)","volume":"12","author":"Roman","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ana.26065","article-title":"ANA Investigates: Neurological Complications of COVID-19 Vaccines","volume":"89","author":"Samudralwar","year":"2021","journal-title":"Ann. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1177\/0961203309345730","article-title":"Transverse myelitis and vaccines: A multi-analysis","volume":"18","author":"Kivity","year":"2009","journal-title":"Lupus"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5.099","DOI":"10.1212\/WNL.90.15_supplement.P5.099","article-title":"Development of Transverse Myelitis after Vaccination, A CDC\/FDA Vaccine Adverse Event Reporting System (VAERS) Study, 1985\u20132017","volume":"90","author":"Shah","year":"2018","journal-title":"Neurology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.7861\/clinmed.2021-0470","article-title":"Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination","volume":"21","author":"Notghi","year":"2021","journal-title":"Clin. Med."},{"key":"ref_6","first-page":"1","article-title":"Acute transverse myelitis following SARS-CoV-2 vaccination: A case report and review of literature","volume":"5","author":"Khan","year":"2021","journal-title":"J. Neurol."},{"key":"ref_7","first-page":"e16624","article-title":"SARS-CoV-2 Vaccination-Induced Transverse Myelitis","volume":"13","author":"Tahir","year":"2021","journal-title":"Cureus"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.18071\/isz.74.0273","article-title":"Acute transverse myelitis after inactivated COVID-19 vaccine","volume":"74","author":"Erdem","year":"2021","journal-title":"Ideggyogy. Szle."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"577606","DOI":"10.1016\/j.jneuroim.2021.577606","article-title":"A case of longitudinally extensive transverse myelitis following vaccination against Covid-19","volume":"358","author":"Pagenkopf","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"ref_10","first-page":"1","article-title":"Acute bilateral optic\/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2","volume":"15","author":"Helmchen","year":"2021","journal-title":"J. Neurol."},{"key":"ref_11","first-page":"hcab069","article-title":"COVID-19 vaccination-associated myelitis","volume":"31","author":"Malhotra","year":"2021","journal-title":"QJM"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"577686","DOI":"10.1016\/j.jneuroim.2021.577686","article-title":"Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?","volume":"359","author":"Vegezzi","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"ref_13","unstructured":"(2021, June 09). Taiwan Centers for Disease Control (CDC), Vaccine Adverse Event Reporting System (VAERS), Available online: https:\/\/www.fda.gov.tw\/tc\/includes\/GetFile.ashx?id=f637590432301286539&type=2&cid=37080."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"102749","DOI":"10.1016\/j.amsu.2021.102749","article-title":"Post COVID-19 transverse myelitis; a case report with review of literature","volume":"69","author":"Ahmad","year":"2021","journal-title":"Ann. Med. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2741\/1351","article-title":"Transverse Myelitis: Pathogenesis, diagnosis and treatment","volume":"9","author":"Krishnan","year":"2004","journal-title":"Front. Biosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/S0140-6736(21)01115-6","article-title":"Heterologous prime-boost COVID-19 vaccination: Initial reactogenicity data","volume":"397","author":"Shaw","year":"2021","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1038\/s41467-021-23173-1","article-title":"Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice","volume":"12","author":"Spencer","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Borobia, A.M., Carcas, A.J., P\u00e9rez Olmeda, M.T., Casta\u00f1o, L., Jes\u00fas Bertr\u00e1n, M., Garc\u00eda-P\u00e9rez, J., Campins, M., Portol\u00e9s, A., Gonzalez-Perez, M., and Garc\u00eda Morales, M.T. (2021, July 09). Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS). Available online: https:\/\/ssrn.com\/abstract=3854768.","DOI":"10.2139\/ssrn.3854768"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1056\/NEJMc2110716","article-title":"Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination","volume":"385","author":"Normark","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41591-021-01449-9","article-title":"Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19\/BNT162b2 vaccination","volume":"27","author":"Hammerschmidt","year":"2021","journal-title":"Nat. Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/10\/1010\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:04:51Z","timestamp":1760166291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/10\/1010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,25]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["medicina57101010"],"URL":"https:\/\/doi.org\/10.3390\/medicina57101010","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,25]]}}}